Recent progress in cyclic aryliodonium chemistry: syntheses and applications

X Peng, A Rahim, W Peng, F Jiang, Z Gu… - Chemical …, 2023 - ACS Publications
Hypervalent aryliodoumiums are intensively investigated as arylating agents. They are
excellent surrogates to aryl halides, and moreover they exhibit better reactivity, which allows …

Recent development in indole derivatives as anticancer agent: A mechanistic approach

N Devi, K Kaur, A Biharee… - Anti-Cancer Agents in …, 2021 - ingentaconnect.com
Background: Cancer accounts for several deaths each year. There are multiple FDA
approved drugs for cancer treatments. Due to the severe side effects and multiple drug …

Discovery of the 3-amino-1, 2, 4-triazine-based library as selective PDK1 inhibitors with therapeutic potential in highly aggressive pancreatic ductal adenocarcinoma

D Carbone, M De Franco, C Pecoraro… - International Journal of …, 2023 - mdpi.com
Pyruvate dehydrogenase kinases (PDKs) are serine/threonine kinases, that are directly
involved in altered cancer cell metabolism, resulting in cancer aggressiveness and …

Medicinal perspective of indole derivatives: recent developments and structure-activity relationship studies

D Kumar, S Sharma, S Kalra, G Singh… - Current drug …, 2020 - ingentaconnect.com
Heterocyclic compounds play a significant role in various biological processes of the human
body and many of them are in clinical use due to their diverse, chemical and biological …

Discovery of novel indolyl-1, 2, 4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity

SA Al-Hussain, TA Farghaly, MEA Zaki… - Bioorganic …, 2020 - Elsevier
Targeting VEGFR-2 signaling pathway is well-established as an important approach for the
treatment of solid tumors, particularly renal cancer. Herein, novel indolyl-1, 2, 4-triazole …

Recent development in indole derivatives as anticancer agents for breast cancer

K Kaur, V Jaitak - Anti-Cancer Agents in Medicinal Chemistry …, 2019 - ingentaconnect.com
Background: Breast Cancer (BC) is the second most common cause of cancer related
deaths in women. Due to severe side effects and multidrug resistance, current therapies like …

Synthesis and anticancer evaluation of novel indole based arylsulfonylhydrazides against human breast cancer cells

A Gaur, MN Peerzada, NS Khan, I Ali, A Azam - ACS omega, 2022 - ACS Publications
A series of novel indole based sulfonohydrazide derivatives (5a–k) containing morpholine
heterocyclic ring were synthesized through multistep chemical reactions. The target …

[HTML][HTML] Synthesis, in-silico studies, and biological evaluation of some novel 3-thiazolyl-indoles as CDK2–inhibitors

SM Gomha, MEA Zaki, D Maliwal, RRS Pissurlenkar… - Results in …, 2023 - Elsevier
The essential enzyme cyclin-dependent kinase 2 (CDK2) is a promising target for anticancer
drug development due to its pivotal role in regulating the cell cycle. This study aimed to …

Synthesis of new bioactive indolyl-1, 2, 4-triazole hybrids as dual inhibitors for EGFR/PARP-1 targeting breast and liver cancer cells

MF Youssef, MS Nafie, EE Salama, ATA Boraei… - ACS …, 2022 - ACS Publications
Cancer is the most severe disease worldwide. Every year, tens of millions of people are
diagnosed with cancer, and over half of those people will ultimately die from the disease …

Fluoroindole chalcone analogues targeting the colchicine binding site of tubulin for colorectal oncotherapy

X Liu, J Jin, Y Wu, B Du, L Zhang, D Lu, Y Liu… - European Journal of …, 2023 - Elsevier
Colorectal cancer (CRC) is a common malignancy of the gastrointestinal tract with high
morbidity and mortality. Our previous studies have demonstrated that indole-chalcone …